Lexeo Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LXEO and other ETFs, options, and stocks.

About LXEO

Lexeo Therapeutics, Inc. is a clinical stage genetic medicine company, which engages in the development of therapies for hereditary and acquired diseases. The firm focuses on the medication of genetically defined cardiovascular diseases and sub-group of Alzheimer’s disease.

CEO

R. Nolan Townsend

CEOR. Nolan Townsend

Employees

Employees72

Headquarters

New York, New York

HeadquartersNew York, New York

Founded

2017

Founded2017

Employees

Employees72

LXEO Key Statistics

Market cap

122.16M

Market cap122.16M

Price-Earnings ratio

-1.19

Price-Earnings ratio-1.19

Dividend yield

—

Dividend yield—

Average volume

707.32K

Average volume707.32K

High today

$3.78

High today$3.78

Low today

$3.37

Low today$3.37

Open price

$3.64

Open price$3.64

Volume

587.87K

Volume587.87K

52 Week high

$19.50

52 Week high$19.50

52 Week low

$1.45

52 Week low$1.45

Analyst ratings

100%

of 6 ratings

Buy

100%

Hold

Sell

Lexeo Therapeutics

Why Robinhood?

Lexeo Therapeutics, Inc. is a clinical stage genetic medicine company, which engages in the development of therapies for hereditary and acquired diseases. The firm focuses on the medication of genetically defined cardiovascular diseases and sub-group of Alzheimer’s disease. Show more

LXEO Key Statistics

Analyst ratings

100%

Lexeo Therapeutics, Inc. is a clinical stage genetic medicine company, which engages in the development of therapies for hereditary and acquired diseases. The firm focuses on the medication of genetically defined cardiovascular diseases and sub-group of Alzheimer’s disease.